Researchers at the University of Hong Kong are exploring a novel vaccine strategy aimed at increasing antibody activity throughout the respiratory system and supporting long-term protection against infection. This approach consists of a two-step process— injection plus intranasal booster.
Subscribe to:
Post Comments (Atom)
< + > Why Digital Employee Experience (DEX) is Critical for Healthcare IT
The following is a guest article by Matt Scavetta, CTIO at Future Tech Healthcare organizations are under immense pressure to deliver high-...
No comments:
Post a Comment